Clinical Trial Detail

NCT ID NCT01577745
Title A Phase 1 Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of MEDI0639 in Advanced Solid Tumors
Recruitment Completed
Gender both
Phase Phase I
Variant Requirements No
Sponsors MedImmune LLC
Indications

Advanced Solid Tumor

Therapies

MEDI0639

Age Groups: adult

No variant requirements are available.